InvestorsHub Logo
Followers 27
Posts 1719
Boards Moderated 0
Alias Born 01/18/2020

Re: Number sleven post# 338483

Tuesday, 05/04/2021 3:20:25 PM

Tuesday, May 04, 2021 3:20:25 PM

Post# of 425759
Certainly possible. Do you think the narrowing of scope makes it unlikely to benefit Amarin even if the court finds for Glaxo again? And of course, there's the inevitable appeal.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News